Catalyst Pharm Inc (NQ: CPRX )
11.50 -0.09 (-0.78%) Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Press Releases about Catalyst Pharm Inc
Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year
November 07, 2022
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
October 28, 2022
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.
Topics ETFs Initial Public Offering
Exposures Securities Market
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
September 29, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following